Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01237392 · ClinicalTrials.gov registry record · NA

Ultrasonic Wound Debridement vs. Standard Sharp Debridement

A NA study of Chronic Skin Ulcers, sponsored by Calvary Hospital, Bronx, NY.

Completed
Registry status
NA
Development phase
75
Enrollment target
1
Study location

NCT01237392: Completed NA study of Chronic Skin Ulcers, sponsored by Calvary Hospital, Bronx, NY.

NCT01237392 is a NA study of Chronic Skin Ulcers that has completed, run by Calvary Hospital, Bronx, NY. The registered enrollment target is 75 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01237392, a NA study of Chronic Skin Ulcers, has completed, sponsored by Calvary Hospital, Bronx, NY.

COMPLETED
Registry status
NA
Development phase
75 participants
Enrollment target
1
Study location

Study Summary

A single center, randomized, parallel, clinical outcome trial to compare the rate of healing in chronic wounds debrided with either high energy ultrasonic debridement (with cavitation) or standard of care sharp debridement.

Conditions Studied

Interventions

  • DEVICE Contact ultrasonic debridement device

Study Locations (1)

New York

  • Calvary Hospital Center for Curative and Palliative Wound Care - The Bronx

Trial Details

FieldValue
Enrollment Target 75 participants
Start Date 2008-06
Est. Completion 2011-04
Phase NA
Calvary Hospital, Bronx, NY

5 total trials

What the finished NCT01237392 record still lists

NCT01237392 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 75 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).

The record links to 1 condition, with Chronic Skin Ulcers appearing as the primary indexed condition, and to 1 intervention - of which Contact ultrasonic debridement device is the first listed.

NCT01237392 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT01237392 about?

NCT01237392 is a clinical study titled "Ultrasonic Wound Debridement vs. Standard Sharp Debridement". A single center, randomized, parallel, clinical outcome trial to compare the rate of healing in chronic wounds debrided with either high energy ultrasonic debridement (with cavitation) or standard of care sharp debridement.

What is the current status of trial NCT01237392?

This trial is currently completed. It is a NA study. The enrollment target is 75 participants. The study started on 2008-06. Estimated completion is 2011-04.

What conditions does trial NCT01237392 study?

This clinical trial studies the following conditions: Chronic Skin Ulcers.

What interventions are being tested in trial NCT01237392?

The interventions under investigation include: Contact ultrasonic debridement device (DEVICE).

Who is sponsoring clinical trial NCT01237392?

This trial is sponsored by Calvary Hospital, Bronx, NY, which has 5 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01237392 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

How this trial's enrollment target compares

Where NCT01237392's enrollment target sits among peer trials

75 1069th of 2000 higher than 919 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01535430 · 75 participants

    Assessment of Eloquent Function in Brain Tumor Patients

  • NCT01542879 · 75 participants · Phase 1

    Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer

  • NCT02232191 · 75 participants · Phase 2

    Immunologic Response to Pneumococcal Polysaccharide Vaccine in Splenic Injury Patients

  • NCT02754544 · 75 participants · NA

    Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01237392, the US trial registry maintained by the National Library of Medicine. NCT01237392 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.